Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Public ClinicalTrials.gov record NCT00087022. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence (ARISER)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether monoclonal antibody therapy is effective in treating kidney cancer. PURPOSE: This randomized phase III trial is studying monoclonal antibody therapy to see how well it works in treating patients who have undergone surgery for nonmetastatic primary kidney cancer.
Study identification
- NCT ID
- NCT00087022
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 864 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Oct 2012 (Actual)
- Completion
- Oct 2012 (Actual)
- Last update posted
- Nov 27, 2018
2004 – 2012
United States locations
- U.S. sites
- 39
- U.S. states
- 21
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anchorage | Alaska | 99508 | — |
| Jonsson Comprehensive Cancer Center at UCLA | Los Angeles | California | 90095-1781 | — |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94115 | — |
| Helen F. Graham Cancer Center at Christiana Hospital | Newark | Delaware | 19718 | — |
| Atlantic Urological Associates - Daytona Beach | Daytona Beach | Florida | 32114 | — |
| Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | — |
| Southeastern Research Group | Tallahassee | Florida | 32308 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Augusta Oncology Associates - Walton Way | Augusta | Georgia | 30901 | — |
| North Idaho Urology - Coeur d'Alene | Coeur d'Alene | Idaho | 83814-2668 | — |
| Northeast Indiana Urology, PC | Fort Wayne | Indiana | 46804 | — |
| Holden Comprehensive Cancer Center at University of Iowa | Iowa City | Iowa | 52242-1002 | — |
| Hematology and Oncology Specialists, LLC - Metairie | Metairie | Louisiana | 70006 | — |
| Regional Urology, LLC | Shreveport | Louisiana | 71106 | — |
| Feist-Weiller Cancer Center at Louisiana State University Health Sciences | Shreveport | Louisiana | 71130-3932 | — |
| Werner-Francis Urology Associates, LLC | Greenbelt | Maryland | 20770 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Lahey Clinic Medical Center - Burlington | Burlington | Massachusetts | 01805 | — |
| Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis | St Louis | Missouri | 63110 | — |
| Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Community Care Physicians, PC at Urological Institute of NENY | Albany | New York | 12209 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263-0001 | — |
| AccuMed Research Associates | Garden City | New York | 11530 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Hudson Valley Urology, PC | Poughkeepsie | New York | 12601 | — |
| Our Lady of Mercy Medical Center Comprehensive Cancer Center | The Bronx | New York | 10466 | — |
| Alliance Urology Specialists - Greensboro | Greensboro | North Carolina | 27403 | — |
| Carolina BioOncology Institute | Huntersville | North Carolina | 28078 | — |
| University of Cincinnati | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| Riverside Methodist Hospital Cancer Care | Columbus | Ohio | 43214-3998 | — |
| Urological Associates of Lancaster, Limited | Lancaster | Pennsylvania | 17604 | — |
| Urology Associates | Nashville | Tennessee | 37209 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6838 | — |
| Mary Crowley Medical Research Center at Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Urology Associates of South Texas, PA | McAllen | Texas | 78503 | — |
| Urology San Antonio, PA - Fredericksburg | San Antonio | Texas | 78229 | — |
| Vermont Cancer Center at University of Vermont | Burlington | Vermont | 05405-0110 | — |
| CCOP - Virginia Mason Research Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00087022, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2018 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00087022 live on ClinicalTrials.gov.